# "DOES MYOBLOC™ IMPROVE FUNCTIONAL HAND USE IN YOUNG CHILDREN WITH A HYPERTONIC UPPER EXTREMITY?"

> **NCT00238641** · PHASE1,PHASE2 · COMPLETED · sponsor: **Stanford University** · enrollment: 10 (—)

## Conditions studied

- Cerebral Palsy

## Interventions

- **DRUG:** Botulinum Toxin type B

## Key facts

- **NCT ID:** NCT00238641
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-01
- **Primary completion:** —
- **Final completion:** 2005-05
- **Target enrollment:** 10 (—)
- **Last updated:** 2005-10-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00238641

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00238641, ""DOES MYOBLOC™ IMPROVE FUNCTIONAL HAND USE IN YOUNG CHILDREN WITH A HYPERTONIC UPPER EXTREMITY?"". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00238641. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*